Biblio

Author [ Title(Desc)] Type Year
Filters: Author is Brissot, Eolia  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Mohty, M., Duléry, R., Gauthier, J., Malard, F., Brissot, E., Aljurf, M., Bazarbachi, A., Chabanon, C., Kharfan-Dabaja, M.A., Savani, B.N., et al. (2020). CAR T-cell therapy for the management of refractory/relapsed high-grade B-cell lymphoma: a practical overview.Bone Marrow Transplant.
H
Bazarbachi, A., Labopin, M., Angelucci, E., Gulbas, Z., Ozdoğu, H., Arat, M., de Rosa, L., Pastano, R., Pioltelli, P., Montserrat, R., et al. (2020). Haploidentical transplant with post-transplant cyclophosphamide for T-cell acute lymphoblastic leukemia: a report from the EBMT acute leukemia working party.Biol Blood Marrow Transplant.
I
Stocker, N., Duléry, R., Battipaglia, G., Brissot, E., Médiavilla, C., Sestili, S., Paviglianiti, A., Ledraa, T., Mohty, R., Bazarbachi, A., et al. (2019). Impact of Cyclosporine-A Concentration on Acute Graft-versus-Host Disease Incidence after Haploidentical Hematopoietic Cell Transplantation.Eur J Haematol.
Mohty, R., Brissot, E., Battipaglia, G., Ruggeri, A., Duléry, R., Bonnin, A., Médiavilla, C., Sestili, S., Belhocine, R., Vekhoff, A., et al. (2019). Infectious complications after post-transplantation cyclophosphamide and anti-thymocyte globulin-based haploidentical stem cell transplantation.Br J Haematol.
P
Peric, Z., Cahu, X., Malard, F., Brissot, E., Chevallier, P., Guillaume, T., Gregoire, M., Gaugler, B., and Mohty, M. (2015). Peripheral blood plasmacytoid dendritic cells at day 100 can predict outcome after allogeneic stem cell transplantation.Biol Blood Marrow Transplant.
T
Brissot, E., Labopin, M., Beckers, M.M., Socié, G., Rambaldi, A., Volin, L., Finke, J., Lenhoff, S., Kröger, N., Ossenkoppele, G.J., et al. (2014). Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.Haematologica.
U
Giebel, S., Czyż, A., Ottmann, O., Baron, F., Brissot, E., Ciceri, F., Cornelissen, J.J., Esteve, J., Gorin, N.-C., Savani, B., et al. (2016). Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the acute leukemia working party of the .Cancer.